Drugs / HP-hMG
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT06997900 | Jul 2025 → Aug 2026 overdue | infertility disorder | Clinique Ovo | Recruiting | No outcome recorded |
| Phase 2 | NCT01732094 | Jul 2012 → May 2013 | infertility disorder, ovarian dysfunction | University Hospital Brussels | Completed | No outcome recorded |
| Phase 2 | NCT01732068 | Jul 2012 → May 2013 | infertility disorder, ovarian dysfunction | University Hospital Brussels | Completed | No outcome recorded |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT01816321 | Mar 2013 → May 2016 | infertility disorder, ovarian dysfunction | University Hospital Brussels | Completed | Missed primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT00829075 | Jan 2005 → Dec 2006 | — | Instituto Valenciano de Infertilidad, IVI VALENCIA | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03483545 | Jul 2018 → Jul 2019 | infertility disorder | Dr François Bissonnette | Completed | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 4 | NCT04385342 Comparator | Jun 2020 → May 2022 | — | Mansoura University | Unknown | No outcome recorded |
| Phase 4 | NCT02992808 Comparator | Dec 2016 → Jan 2018 | female infertility | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT02738580 Comparator | Oct 2016 → Jun 2018 | infertility disorder, ovarian hyperstimulation syndrome | Instituto Valenciano de Infertilidad, IVI VALENCIA | Completed | No outcome recorded |
| Phase 4 | NCT01345812 Comparator | Apr 2011 → Jul 2012 | — | University of Aarhus | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT01888744 Comparator | Sep 2010 → Jun 2013 | infertility disorder | University Hospital Brussels | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hp-HMG | “Does ovarian stimulation with highly purified (hp)-HMG protect from elevated progesterone in the follicular phase compared to recombinant FSH (r-FSH) cycles through a different...” PMID 38037188 ↗ Feb 2024 |
| Known as | Menopur | “Furthermore, the MARCS study showed that combining REKOVELLE with highly purified hMG (MENOPUR) led to higher number of retrieved oocytes and improved blastulation rate...” NCT06997900 ↗1“Menopur (Highly Purified Human Menopausal Gonadotropin)” NCT03483545 ↗ |
| Modality | Protein / enzyme biologic | “highly purified human menopausal gonadotropin (hp-HMG)” NCT01888744 ↗ |